NMPA Roundup April 2023

Here’s the latest China NMPA regulatory and clinical affairs news for medical device and IVDs pros in April 2023. These updates are presented by China Med Device, LLC, your partner in Chinese market access.

Policies

247 Guidelines Impacted by 2023 Revisions Plan

The NMPA published the “2023 Medical Device Guidelines Revisions Plan” on April 4, 2023, in which 247 guidelines are affected. The plan involves the guidelines for technical review for type testing, clinical trial and registration, and Indication for Use (IFU) writing. It impacts 63 new Class III, 66 new Class II and 118 revised Class II devices guidelines.

Class III guidelines include those for hemodialysis equipment, single-photon emission/X-ray computed tomography system, positron emission/magnetic resonance imaging system, laparoendoscopic surgical system, high-frequency surgical instruments for flexible endoscopes, abdominal endoscopic surgical system, peripheral vascular stents, thrombectomy stents, etc. For the complete list of guidelines please click HERE

Error Correction Matters Added into Electronic Filing System

The NMPA issued a notice on April 19, adding error correction matters into their electronic Regulated Product Submission (eRPS) system, effective on April 20, 2023.

It also attached “folder structure of the electronic catalogue of declaration materials” as annex. For more information click HERE

Software Company Defects Found in Unannounced Inspection

The NMPA conducted a “fly inspection”, also known as an unannounced inspection, on Chenfang Sichuang Technology Co., Ltd. According to the notice published on April 17, 2023, the inspection found that the QMS issues from the perspectives of institution and personnel, design & development, and production management. For our comprehensive review click HERE

Guidelines & Standards

Final Guideline on RF Aesthetic Devices Issued

The NMPA released the final version of “Registration Guideline for Radiofrequency Aesthetic Devices” on April 12, 2023.

The 29-page RF equipment guideline elaborates the review focus areas: registration unit division, performance index requirements, electrical safety requirements, software research, biological research, etc. For our comprehensive review please click HERE

Priority Approvals

Two Imported Devices Gain Innovation Approval in April

NMPA granted innovation approvals to seven devices in April 2023, for indications ranging from cardiovascular, orthopedic, neurology and ophthalmic. Among them are two imported devices from Alcon and Ubiosis. Click HERE for more information

• SEO Powered Content & PR Distribution. Get Amplified Today.
• PlatoAiStream. Web3 Data Intelligence. Knowledge Amplified. Access Here.
• Minting the Future w Adryenn Ashley. Access Here.
• Buy and Sell Shares in PRE-IPO Companies with PREIPO®. Access Here.
• Source: https://chinameddevice.com/nmpa-medical-device-april/